Roivant Sciences Ltd.

How funds and institutional managers reported voting their shares, year to 30 June 2026

Filers reporting: 413year to 30 June 2026
Against management on pay: 70.1%270 of 385 reporting filers
Same, by reported shares: 72.3%shares reported on Form N-PX
Meetings on file: 3across 3 seasons

26.6% for65.6% against7.8% other70.1% against management410 filers on say-on-pay

foragainstabstain, withhold or otheramber tick: the portion cast against management

For the year to 30 June 2026, 413 funds and managers listed Roivant Sciences Ltd. in their Form N-PX filings (one meeting).

On the advisory vote on executive pay, 270 of the 385 filers that reported a position voted against management (70.1%), 63.6 percentage points above the median company on this site (6.6%). By reported shares the figure is 72.3% (median 2.9%). These are shares of the filers reporting on Form N-PX, not of all votes cast at the meeting.

Among the largest fund families, 7 voted with management on pay and 37 voted against: BNY Mellon, Fidelity, Northern Trust and FlexShares, Thrivent, Dimensional, American Century, Principal and Franklin Templeton and others.

Meetings

Meeting date	Season	Filers reporting	Items	Against management on pay
10 Sep 2025	year to 30 June 2026	411	3	70.1%
10 Sep 2024	year to 30 June 2025	368	4	24.6%
12 Sep 2023	year to 30 June 2024	100	2	not reported

Meetings with 20 or more reporting filers have their own page with every item. Dates are as filers typed them; dates up to three days apart are treated as one meeting.

Say-on-pay: this company and the median

year to 30 June 2026	Roivant Sciences Ltd.	Median company
Reporting filers voting against management	70.1%	6.6%
Reported shares voted against management	72.3%	2.9%

Among filers reporting on Form N-PX. The median is over 3,799 companies with a say-on-pay item reported by 20 or more filers.

How the largest families voted

Meeting of 10 Sep 2025: say-on-pay and each shareholder proposal that could be told apart.

Family	Say-on-pay
Vanguard	Against *
BlackRock and iShares	Against *
Fidelity	Against *
Dimensional	Against *
State Street and SPDR	Against *
American Century	Against *
Franklin Templeton	Against *
Invesco	Against *
Equitable	For
Charles Schwab	Against *
Nuveen and TIAA	For
ProShares and ProFunds	Against *
John Hancock and Manulife	Against *
Morgan Stanley, Eaton Vance and Calvert	For
J.P. Morgan	Against *
Goldman Sachs	For
WisdomTree	Against *
PGIM and Prudential	For
Jackson National funds	Against *
Northern Trust and FlexShares	Against *
SEI	Against *
T. Rowe Price	Against *
Thrivent	Against *
Lincoln Financial	Against *
Voya	Against *
First Trust	Against *
Russell Investments	Against *
Nationwide	Against *
Victory Capital	Against *
Brighthouse Funds	For
Guggenheim and Rydex	Against *
Columbia Threadneedle	Against *
BNY Mellon	Against *
Principal	Against *
Pacific Life funds	Against *
Transamerica	For
Federated Hermes	Against *
AllianceBernstein	Against *
Allspring	Against *
MassMutual	Against *
Macquarie and Delaware Funds	Against *
Janus Henderson	Against *
Neuberger Berman	Against *
Natixis and Loomis Sayles	Against *

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

By season

Season	Filers reporting	Against management on pay, filers	By reported shares
year to 30 June 2024	102	not reported	not reported
year to 30 June 2025	370	24.6%	17.5%
year to 30 June 2026	413	70.1%	72.3%

Category mix

Share of the vote records reported for this company, by the category filers chose.

Category	Vote records	Share
DIRECTOR ELECTIONS	1,970	44.0%
SECTION 14A SAY-ON-PAY VOTES	1,788	40.0%
AUDIT-RELATED	715	16.0%

Questions

How did large funds vote at Roivant Sciences Ltd.?

For the year to 30 June 2026, 385 Form N-PX filers reported a say-on-pay vote at Roivant Sciences Ltd.; 270 voted against management (70.1%). The table on this page lists the position of each of the largest fund families on say-on-pay and on each shareholder proposal that could be told apart in the filings.

Were there shareholder proposals at Roivant Sciences Ltd.?

No proposal from security holders was reported by enough filers to be shown for the year to 30 June 2026.

Is this the meeting result?

No. The figures are shares of the funds and managers that file Form N-PX, and of the shares they reported. Holders that do not file the form (individuals, most foreign investors, insiders) are not included, so the split here can differ widely from the certified result, which Roivant Sciences Ltd. reports on Form 8-K.

Where does the data come from?

From Form N-PX filings on the SEC's EDGAR system, grouped by company. Filers type company names and meeting dates themselves; this site groups spellings of the same company and folds meeting dates up to three days apart. Data runs through 23 Sep 2026; the median compares 3,799 companies.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Roivant Sciences Ltd., grouped by company. The name is the most common spelling among filers; the ticker and SEC company number come from the SEC company tickers file, matched on the exact name. Not verified by the SEC. Filings read through 23 Sep 2026; page built 26 Sep 2026.